Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
April 21, 2022Cell ReportsOpen Access

Nasally delivered interferon-λ protects mice against infection by SARS-CoV-2 variants including Omicron

View Full Paper
Ask AI
Bookmark
Share

Authors

ZCZhenlu ChongWashington University in St. LouisCKCourtney E. KarlWashington University in St. LouisPHPeter HalfmannUniversity of North Carolina at Chapel Hill

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Chong et al. (2022) studied this question.

synapsesocial.com/papers/6ab73a3defb785c3fa62dd8fhttps://doi.org/10.1016/j.celrep.2022.110799
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Prevention and cure of rotavirus infection via TLR5/NLRC4–mediated production of IL-22 and IL-182014 · 225 citations
  2. 2Lethality of SARS-CoV-2 infection in K18 human angiotensin-converting enzyme 2 transgenic mice2020 · 421 citations
  3. 3Critical Role of Type III Interferon in Controlling SARS-CoV-2 Infection in Human Intestinal Epithelial Cells2020 · 366 citations
  4. 4COVID-19 and emerging viral infections: The case for interferon lambda2020 · 209 citations
  5. 5Ten emerging SARS-CoV-2 spike variants exhibit variable infectivity, animal tropism, and antibody neutralization2021 · 61 citations